Medtronic plc (MDT)
Medtronic (MDT) Stock Dips While Market Gains: Key Facts
In the closing of the recent trading day, Medtronic (MDT) stood at $94.21, denoting a -1.76% move from the preceding trading day.
Medtronic (MDT) Stock Sinks As Market Gains: Here's Why
The latest trading day saw Medtronic (MDT) settling at $95.34, representing a -1.24% change from its previous close.
Medtronic Stock's $50 Billion Gift To Investors
In the last decade, Medtronic (MDT) stock has returned a notable $52 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let's look at some numbers and compare how this payout power stacks up against the market's biggest capital-return machines.
Medtronic (MDT) Falls More Steeply Than Broader Market: What Investors Need to Know
Medtronic (MDT) concluded the recent trading session at $96.5, signifying a -1.4% move from its prior day's close.
Medtronic plc - Special Call
Medtronic plc - Special Call Company Participants Ryan Weispfenning - VP & Head of Investor Relations Emily Elswick Conference Call Participants Ryan Zimmerman - BTIG, LLC, Research Division Nathan Treybeck - Wells Fargo Securities, LLC, Research Division Christopher Pasquale - Nephron Research LLC Shagun Singh Chadha - RBC Capital Markets, Research Division Michael Polark - Wolfe Research, LLC Danielle Antalffy Presentation Ryan Weispfenning VP & Head of Investor Relations Okay. Hello, everyone.
The Rotation To Value Is On – 5 October Surprise High-Yield Picks
An “October Surprise” is usually a significant, late-breaking news event that generally occurs just before a November election and has the potential to influence its outcome.
Medtronic (MDT) Beats Stock Market Upswing: What Investors Need to Know
Medtronic (MDT) closed the most recent trading day at $97.7, moving +2.33% from the previous trading session.
Medtronic plc (MDT) Presents at Bank of America Global Healthcare Conference 2025 Transcript
Medtronic plc (NYSE:MDT ) Bank of America Global Healthcare Conference 2025 September 24, 2025 9:10 AM EDT Company Participants Thierry Pieton - Executive VP & CFO Presentation Unknown Analyst We're glad to have the Medtronic CFO, Thierry Pieton, here with us. So welcome.
Medtronic: Buy This Dividend Aristocrat While It's Good Value
Medtronic remains a Buy for long-term investors, offering steady growth, durable income, and an attractive valuation below historical averages. MDT delivered solid fiscal Q1 2026 results, with 8.4% revenue growth and standout performance in Cardiac Ablation and Diabetes segments. The upcoming diabetes segment spinoff is expected to improve operating margins and reinforce MDT's growth trajectory.
Medtronic Plc (MDT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Medtronic plc (NYSE:MDT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:50 PM EDT Company Participants Thierry Pieton - Executive VP & CFO Conference Call Participants Patrick Wood - Morgan Stanley, Research Division Presentation Patrick Wood MD of Equity Research I think we'll kick things off. Thanks so much, everybody.
MDT Stock May Benefit From New Regulatory Wins for Its MiniMed 780G
Medtronic secures FDA milestones for its MiniMed 780G system, expanding use to type 2 diabetes and enabling sensor integration.
Medtronic Plc (MDT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
Medtronic plc (NYSE:MDT ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:00 AM EDT Company Participants Geoffrey Martha - Chairman of the Board & CEO Thierry Pieton - Executive VP & CFO Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst Okay. Good morning.
